Clinical Trial Update: Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer [NA]

View source ↗

Summary

A clinical trial evaluating whether urine tumor DNA can be used to de-intensify surveillance in patients with non-muscle invasive bladder cancer; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Snippet

Sponsor: Lahey Clinic | Conditions: Non-muscle Invasive Bladder Cancer (NMIBC) | NA | Status: RECRUITING